IRS 990 Nonprofit Profile

Collaborative Trajectory Analysis Project

To advance understanding of disease progression in duchenne muscular dystrophy by fostering collaboration among regulators, clinical experts, drug developers, and patient groups. the organization develops data-driven tools and insights to support drug development, shares findings broadly across the duchenne community, and works to accelerate clinical research and deliver improved therapies to patients sooner.

Filing year
2024
Total revenue
$1.9M
Total expenses
$1.1M
Program expenses
$756K
Administration
$197K
Fundraising
$117K
Program share of expenses
71%
EIN
934558784
Location
Cambridge, MA

CTAP-NMD.ORG

Machine-readable CharitySense data

Agents and crawlers can fetch structured JSON for this charity:

About CharitySense

CharitySense provides live, independent intelligence from the charitable infrastructure you fund — hospitals, schools, orphanages, and clinics anywhere in the world.

See live projects or read our insights on nonprofit accountability.

Financial data on this page is sourced from IRS Form 990 filings.